Feed NHI
NH

National Health Investors, Inc. NHI NYSE · Real estate · United States

$62.47 +4.15% +$2.49

Summary

87 / 100 · Bulios Score

What speaks for it

  • Earnings per share grew by 81% a year over the last 3 years.
  • Out of every 100 USD of revenue, 153 USD is left as net profit.
  • The share price is below the Bulios Fair Price.

What to watch

  • Earnings per share swing sharply from year to year.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $62.47

By our assumptions the business is worth more than its shares cost today.

P/E today 4.4 82% lower
5-year average P/E 24.8
P/E today 4.4
REIT - Healthcare Facilities industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 4.4 USD for 1 USD of yearly profit. Over the last five years it was 24.8 USD on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 2.6% a year over 5 years. Over the last 3 years it grew by 11% a year. Earnings per share grew by 81% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Net profit, industry median (REIT - Healthcare Facilities) 18 USD

Out of every 100 USD of revenue, 153 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Mostly

Repaying all its debt would take 5.0 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Moderate, stretched
Yield
5.92%
Paid out of profit
26%
Raised in a row
1 year

You receive $3.70 per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

Neutral

Today's price within the analysts' price targets

The average target of $77.4 is 24% above today's price. 32% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

The company reports no revenue by region.

Real Estate Investment Segment brings in 79% of revenue. Senior Housing Operating Portfolio grew fastest, by 31% a year.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy